N-Myristoyltransferase (NMT) is a potential drug target in Leishmania parasites. Scaffold-hopping from published inhibitors yielded the serendipitous discovery of a chemotype selective for Leishmania donovani NMT; development led to high affinity inhibitors with excellent ligand efficiency. The binding mode was characterised by crystallography and provides a structural rationale for selectivity
Previous research has provided pre-clinical validation for inhibition of the enzyme N-myristoyltrans...
Inhibition of N-myristoyltransferase has been validated pre-clinically as a target for the treatment...
The leishmaniases are a spectrum of global diseases of poverty associated with immune dysfunction an...
N-Myristoyltransferase (NMT) is a potential drug target in Leishmania parasites. Scaffold-hopping fr...
Inhibitors of Leishmania N-myristoyltransferase (NMT), a potential target for the treatment of leish...
Inhibitors of Leishmania N-myristoyltransferase (NMT), a potential target for the treatment of leish...
Inhibitors of Leishmania <i>N</i>-myristoyltransferase (NMT), a potential target for the treatment o...
ABSTRACT: Inhibitors of Leishmania N-myristoyltransferase (NMT), a potential target for the treatmen...
The leishmaniases are a spectrum of global diseases of poverty associated with immune dysfunction an...
Leishmaniasis is a disease caused by the Leishmania genus of protozoan parasites, and spread by the ...
Leishmaniasis is a disease caused by the Leishmania genus of protozoan parasites, and spread by the ...
Inhibitors of Leishmania N-myristoyltransferase (NMT), a potential target for the treatment of leish...
The leishmaniases, caused by Leishmania species of protozoan parasites, are neglected tropical disea...
N-Myristoyltransferase (NMT) is a potential drug target in Leishmania parasites. Scaffold-hopping fr...
The leishmaniases are a spectrum of global diseases of poverty associated with immune dysfunction an...
Previous research has provided pre-clinical validation for inhibition of the enzyme N-myristoyltrans...
Inhibition of N-myristoyltransferase has been validated pre-clinically as a target for the treatment...
The leishmaniases are a spectrum of global diseases of poverty associated with immune dysfunction an...
N-Myristoyltransferase (NMT) is a potential drug target in Leishmania parasites. Scaffold-hopping fr...
Inhibitors of Leishmania N-myristoyltransferase (NMT), a potential target for the treatment of leish...
Inhibitors of Leishmania N-myristoyltransferase (NMT), a potential target for the treatment of leish...
Inhibitors of Leishmania <i>N</i>-myristoyltransferase (NMT), a potential target for the treatment o...
ABSTRACT: Inhibitors of Leishmania N-myristoyltransferase (NMT), a potential target for the treatmen...
The leishmaniases are a spectrum of global diseases of poverty associated with immune dysfunction an...
Leishmaniasis is a disease caused by the Leishmania genus of protozoan parasites, and spread by the ...
Leishmaniasis is a disease caused by the Leishmania genus of protozoan parasites, and spread by the ...
Inhibitors of Leishmania N-myristoyltransferase (NMT), a potential target for the treatment of leish...
The leishmaniases, caused by Leishmania species of protozoan parasites, are neglected tropical disea...
N-Myristoyltransferase (NMT) is a potential drug target in Leishmania parasites. Scaffold-hopping fr...
The leishmaniases are a spectrum of global diseases of poverty associated with immune dysfunction an...
Previous research has provided pre-clinical validation for inhibition of the enzyme N-myristoyltrans...
Inhibition of N-myristoyltransferase has been validated pre-clinically as a target for the treatment...
The leishmaniases are a spectrum of global diseases of poverty associated with immune dysfunction an...